Solaris Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-850
Closed -$69K 247
2017
Q3
$69K Hold
850
0.04% 150
2017
Q2
$60K Sell
850
-25,017
-97% -$1.66M 0.04% 161
2017
Q1
$1.76M Buy
25,867
+845
+3% +$59.4K 1.15% 30
2016
Q4
$1.79M Sell
25,022
-13,599
-35% -$1.01M 1.16% 32
2016
Q3
$3.06M Buy
38,621
+894
+2% +$72.6K 1.93% 22
2016
Q2
$3.15M Sell
37,727
-675
-2% -$59.9K 2.27% 23
2016
Q1
$3.53M Sell
38,402
-310
-0.8% -$28K 2.48% 15
2015
Q4
$3.92M Buy
38,712
+2,309
+6% +$240K 2.68% 11
2015
Q3
$3.57M Buy
36,403
+271
+0.8% +$30.1K 2.84% 10
2015
Q2
$4.23M Sell
36,132
-125
-0.3% -$13.7K 2.62% 7
2015
Q1
$3.56M Buy
36,257
+5,521
+18% +$561K 2.2% 11
2014
Q4
$2.9M Sell
30,736
-50
-0.2% -$5.17K 1.87% 22
2014
Q3
$3.28M Sell
30,786
-375
-1% -$36.7K 2.19% 12
2014
Q2
$2.58M Buy
31,161
+1,925
+7% +$150K 1.69% 25
2014
Q1
$2.07M Buy
29,236
+1,211
+4% +$95K 1.43% 31
2013
Q4
$2.1M Buy
+28,025
New +$1.95M 1.41% 30

Other funds holding GILD

Solaris Asset Management's GILD Position: Q4 2017 in Review

Solaris Asset Management sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 850 shares — an estimated $69K sold.

Solaris Asset Management first reported a position in GILD in Q4 2013 and held it in 16 quarters. The position peaked at $4.23M in Q2 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Solaris Asset Management reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Solaris Asset Management sold 850 Gilead Sciences shares in Q4 2017, an estimated $69K.
  • Solaris Asset Management first reported a position in Gilead Sciences in Q4 2013 and held it in 16 quarters.
  • Solaris Asset Management's Gilead Sciences position peaked at $4.23M in Q2 2015.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Solaris Asset Management's 13F filing for Q4 2017, filed 16 Jan 2018.